Sign in
8-K

Current Report

Stoke Therapeutics, Inc. Filed Acc 0001193125-23-004192

Regulation FD disclosure · Other events

  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading d427248d8k.htm…